Back to Results
First PageMeta Content
Pain / Pharmacology / Analgesics / Gabapentin / Pharmaceutical sciences / Parke-Davis / Off-label use / Neuropathic pain / Postherpetic neuralgia / Pfizer / Medicine / Health


Document Date: 2013-01-04 13:10:33

Open Document

File Size: 329,68 KB

Share Result on Facebook

Company

Parke-Davis / PLAN INC. / PFIZER INC. / Two Marketing Partnerships / Aetna Inc. / Warner-Lambert / Guardian Life Insurance Company / Warner-Lambert Company / Kaiser / /

Country

United States / /

Currency

USD / /

Event

Judicial Event / FDA Phase / /

Facility

Southern California Pharmacy / /

IndustryTerm

direct communications / advertising supplements / medical insurance / treatment for epilepsy / Epilepsy Treatment / snake oil / treatment of bipolar disorder / pharmaceutical / non-profit healthcare / /

MedicalCondition

Post-Herpetic Neuralgia / Migraine / Pain / injury / epilepsy / G. Injury / Bipolar Disorder / /

Organization

Food and Drug Administration / Southern California Pharmacy and Therapeutics Committee / UN Court / Therapeutics Committee / FDA / /

Person

Mathew Trial / Van de Vusse / Tai Trial / H. Neurontin / /

Position

chairperson / representative / U.S.D.J. / officer / /

Product

NEURONTIN / Post-Herpetic Neuralgia / /

ProvinceOrState

California / Massachusetts / /

PublishedMedium

the Cochrane Review / /

Region

Southern California / /

SocialTag